Three new cancer therapies recently approved by the Federal Drug Administration (FDA) – avelumab (BAVENCIO®),...

“NCI and Industry: Moving Innovations from the Lab to Patients” was the feature article in March 2019 edition of...

NCI TTC and the Frederick National Laboratory for Cancer Research (FNLCR) will host the 2019 Technology Showcase on June 12....

Advances in the rapidly growing field of immunotherapy are being realized as evidenced by several ground-breaking, new...